Introduction: ventriculo-arterial impedance (ZV a ) is recognised as influencing exercise tolerance, sincope onset and prognosis in aortic stenosis (AS) patients Aim: of the present study is to show that increase in ZV a is associated with impairment of left ventricular (LV) function and adverse outcome in AS.
Background:
The management of asymptomatic patients with severe aortic stenosis (AS) is extremely controversial. There are very few data regarding the assessment, determinants and prognostic value of left ventricular contractile reserve (LVCR) in these patients. We aimed to quantify LVCR and to evaluate its determinants and usefulness for risk stratification in asymptomatic patients with severe AS.
Methods and results:
Asymptomatic patients with severe AS (n=150, aortic valve area<1cm², 70±9 years, 64% of male) and preserved left ventricular (LV) systolic function (LV ejection fraction ≥55%) were prospectively referred to exercise stress echocardiography. Using 2D speckle tracking analysis, LVCR was defined as an exercise-induced changes in LV global longitudinal strain >2%. LVCR was present in 62 patients (41%) and there was no significant difference between LVCR and no LVCR groups regarding demographic, clinical and exercise data, as well as risk factors. Using multiple linear regression, after adjustment for age, sex and E/Ea ratio, the independent determinant of exercise-induced changes in LV global longitudinal strain were aortic mean pressure gradient (p=0.005), LV ejection fraction (p=0.035) and exercise indexed LA area (p=0.002). During a mean follow-up of 19±12 months, 76 events (51%) occurred. The absence of LVCR was associated with reduced 4-year cardiac event-free survival (26±6 vs. 53±11%, p<0.0001). By opposition, exercise-induced changes in LV ejection fraction did not predict the outcome (p=0.96). In multivariate analysis, the independent predictors of events were resting brain natriuretic peptide level (p<0.0001), aortic mean pressure gradient (p=0.037), exercise cardiac output (p=0.004) and absence of LVCR (HR=1.8, 95%CI: 1.05-3.08, p=0.033).
Conclusion:
In asymptomatic patients with severe AS, the main determinants of LVCR, as assessed using exercise-induced changes in LV global longitudinal strain, were related to AS severity and exercise LA size. The absence of LVCR is a powerful predictor of reduced cardiac event-free survival. These results strongly support the use of exercise stress echocardiography in asymptomatic AS.
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Prognostic value of NT-proBNP in Algerian patients with asymptomatic aortic stenosis Ilyes Bouaguel, Hocine Foudad, Aziz Trichine, Rachid Merghit Hôpital militaire, Cardiologie, Constantine, Algérie Introduction and objectives: Aortic stenosis (AS) is the most common valve disease. Aortic valve replacement (AVR) is the treatment of choice in symptomatic patients with severe AS. Our objective was to assess the prognostic value of NT-proBNP in Algerian patients with asymptomatic moderate/ severe aortic.
Methods:
Prospective study of 225 patients with degenerative asymptomatic moderate/severe aortic stenosis. NT-proBNP was determined in all patients, who were then followed up clinically. A clinical event was defined as surgery, hospital admission due to angina, heart failure or syncope, or death.
Results: A total of 51% were women, and the mean age was 74 years. Mean (SD) echocardiographic values were as follows: peak velocity 4.14 (0.87) m/s; mean gradient, 43.2 (16.0) mmHg; aortic valve area, 0.87 (0.72) cm 2 , and aortic valve area index, 0.49 (0.14) cm 2 /m 2 . The median NT-pro-BNP value was 490.0 [198.0-1312 .0] pg/mL. There were 139 events during followup (median 12 months). The optimum NT-proBNP cut-point was 515 pg/mL, giving event-free survival rates at 6 months and 1 years of 93% and 57%, respectively, in patients with NT-proBNP <515 pg/mL compared with 50% and 31% in those with NT-proBNP >515 pg/mL.
Conclusions:
NT-proBNP determination provides prognostic information in patients with asymptomatic moderate/severe aortic stenosis. From 2010 to end 2014, 9 patients underwent tricuspid VIV implantation. There were 4 females and 5 males. Pts were in functional NYHA class III. Seven pts had congenital heart disease, 1 pt a rheumatic disease, 1 pt a cardiomyopathy. Causes for implantation were tricuspid stenosis (n = 4), a mixed lesion combining tricuspid stenosis and regurgitation (n = 4), and one tricuspid regurgitation. In addition, 2 of them suffered from protein losing enteropathy (PLE).
Implantation was performed under general anaesthesia using a femoral approach at a mean age of 29.5±18 years (9-60 years). Two pts underwent pre-dilatation of the lesion and a pre-stenting was performed in 6. VIV implantation was realized under pacing in 3 pts. A 22-mm Melody valve (Medtronic) was implanted in 6 pts, and an Edwards Sapien valve in 3 (one 23-mm, one 26mm, and one 29-mm valve). Implantation succeeded in all despite 2 embolizations (1 in RA and 1 in RV); the embolized stent could be stabilized within the tricuspid annulus in both by a self-expandable stent before subsequent successful VIV implantation using a second valved stent. During follow-up (mean 10 months and up to 24 months), all pts but one were clinically ameliorated (mean functional NYHA class II) including the 2 pts with PLE (increase in albumin level). The mean tricuspid gradient decreased significantly from 9.4±2.3mm Hg before to 3.9±0.4mm Hg after implantation. Two pts died during follow-up but death was not valved stent related.
To conclude, tricuspid VIV implantation is an effective procedure using both the Melody and the Edwards Sapien valves. Knowledge of the true minimal diameter is the key point to choose the appropriate valved stent. This promising technique has good immediate and mid-term results but further studies with longer follow-up and including more pts are necessary Introduction: Functional tricuspid regurgitation (TR) is probably the most common and anticipated complication of left-sided heart valve pathology, especially mitral valve diseases. Whether preoperative functional TR will regress or progress after successful left-sided valve surgery is unknown. The aim of this study was to identify the predictors of significant TR after successful left-sided valve surgery.
